Eiger BioPharmaceuticals Announces Key Executive Appointments
Eiger BioPharmaceuticals, a commercial-stage biopharmaceutical company, announced on Wednesday the appointment of William G. Kachioff as Chief Financial Officer and James A. Vollins as General Counsel, Chief Compliance Officer, and Corporate Secretary. The company, which is focused on developing innovative therapies for hepatitis delta virus (HDV) and other serious diseases, said the appointments come at…
